Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Scientists create 'malaria resistant' mosquitos
Mosquito larvae
By using a gene editing tool called CRISPR, scientists were able to prevent malaria transmission being passed down to 99.5 per cent of offspring.
Findings offer hope for future elimination of the disease
 
US scientists say they have managed to create a genetically modified mosquito that can block malaria infection, preventing its ability to transmit the disease to humans.

While further work is needed, the discovery could one day help to eradicate a disease that kills nearly a million people every year.

Scientists from the University of California (UC) inserted DNA into the germ line of Anopheles stephensi mosquitos - a leading malaria vector in Asia.

This prevented malaria transmission being passed on to 99.5 per cent of the insects' progeny, according to results published in the journal PNAS.

The UC team used a gene editing tool called CRISPR, which allows access to the cell nucleus to snip DNA for replacing mutated genes or inserting new ones.

"This is a significant first step," said Anthony James, a distinguished professor from UC's Irvine campus. "We know the gene works. The mosquitoes we created are not the final brand, but we know this technology allows us to efficiently create large populations."

Malaria is one of the world's leading health concerns, affecting 300-500 million people every year. Over 40 per cent of the world's population live in areas where there is a risk of contracting the disease.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'